SK279197B6 - N-benzylindoly a farmaceutické prostriedky ich obs - Google Patents

N-benzylindoly a farmaceutické prostriedky ich obs Download PDF

Info

Publication number
SK279197B6
SK279197B6 SK2380-91A SK238091A SK279197B6 SK 279197 B6 SK279197 B6 SK 279197B6 SK 238091 A SK238091 A SK 238091A SK 279197 B6 SK279197 B6 SK 279197B6
Authority
SK
Slovakia
Prior art keywords
hydrogen
ethenyl
alkyl
mmol
benzyl
Prior art date
Application number
SK2380-91A
Other languages
English (en)
Slovak (sk)
Inventor
Jeremy Gilmore
Alec Todd
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016790A external-priority patent/GB9016790D0/en
Priority claimed from GB919107486A external-priority patent/GB9107486D0/en
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of SK279197B6 publication Critical patent/SK279197B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK2380-91A 1990-07-31 1991-07-30 N-benzylindoly a farmaceutické prostriedky ich obs SK279197B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016790A GB9016790D0 (en) 1990-07-31 1990-07-31 Pharmaceutical compounds
GB919107486A GB9107486D0 (en) 1991-04-09 1991-04-09 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
SK279197B6 true SK279197B6 (sk) 1998-07-08

Family

ID=26297410

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2380-91A SK279197B6 (sk) 1990-07-31 1991-07-30 N-benzylindoly a farmaceutické prostriedky ich obs

Country Status (24)

Country Link
EP (1) EP0469833B1 (pt)
JP (1) JP3220191B2 (pt)
KR (1) KR0179985B1 (pt)
CN (1) CN1040108C (pt)
AT (1) ATE184280T1 (pt)
AU (1) AU654140B2 (pt)
CA (1) CA2048096C (pt)
CZ (1) CZ279932B6 (pt)
DE (1) DE69131592T2 (pt)
DK (1) DK0469833T3 (pt)
ES (1) ES2137158T3 (pt)
FI (1) FI102536B1 (pt)
GR (1) GR3032038T3 (pt)
HU (2) HU213604B (pt)
IE (1) IE912670A1 (pt)
IL (1) IL98990A (pt)
MX (1) MX9100414A (pt)
MY (1) MY131141A (pt)
NO (1) NO300133B1 (pt)
NZ (1) NZ239168A (pt)
PH (1) PH30487A (pt)
PT (1) PT98475B (pt)
SK (1) SK279197B6 (pt)
YU (1) YU47839B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
US5273986A (en) * 1992-07-02 1993-12-28 Hoffmann-La Roche Inc. Cycloalkylthiazoles
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
US6160120A (en) * 1996-11-19 2000-12-12 Eli Lilly And Company Process for preparing n-benzyl indoles
GB9523948D0 (en) * 1995-11-23 1996-01-24 Univ East Anglia Process for preparing n-benzyl indoles
RU2007115522A (ru) * 2004-10-12 2008-10-27 Декод Дженетикс Ехф (Is) Пери-замещенные бициклические карбоновые кислоты для лечения окклюзионного заболевания артерий

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4970207A (en) * 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives

Also Published As

Publication number Publication date
AU654140B2 (en) 1994-10-27
ATE184280T1 (de) 1999-09-15
IE912670A1 (en) 1992-02-12
EP0469833B1 (en) 1999-09-08
KR920002582A (ko) 1992-02-28
DE69131592T2 (de) 2000-01-20
NO912963D0 (no) 1991-07-30
IL98990A0 (en) 1992-07-15
NO300133B1 (no) 1997-04-14
PT98475B (pt) 1997-11-28
CZ279932B6 (cs) 1995-08-16
CS238091A3 (en) 1992-03-18
DK0469833T3 (da) 1999-12-20
CA2048096A1 (en) 1992-02-01
FI913639A (fi) 1992-02-01
CN1040108C (zh) 1998-10-07
HU213604B (en) 1997-08-28
YU132591A (sh) 1994-01-20
IL98990A (en) 1995-06-29
EP0469833A1 (en) 1992-02-05
KR0179985B1 (ko) 1999-03-20
PT98475A (pt) 1992-06-30
MY131141A (en) 2007-07-31
YU47839B (sr) 1996-01-09
DE69131592D1 (de) 1999-10-14
CA2048096C (en) 2002-09-17
CN1061413A (zh) 1992-05-27
MX9100414A (es) 1992-02-28
GR3032038T3 (en) 2000-03-31
FI913639A0 (fi) 1991-07-30
ES2137158T3 (es) 1999-12-16
HUT60491A (en) 1992-09-28
NZ239168A (en) 1993-05-26
JP3220191B2 (ja) 2001-10-22
PH30487A (en) 1997-05-28
FI102536B (fi) 1998-12-31
FI102536B1 (fi) 1998-12-31
NO912963L (no) 1992-02-03
HU211952A9 (en) 1996-01-29
HU912535D0 (en) 1992-01-28
JPH06220045A (ja) 1994-08-09
AU8139991A (en) 1992-02-06

Similar Documents

Publication Publication Date Title
US5681954A (en) Piperazine derivatives
AU677644B2 (en) Piperazine derivatives
JP2722279B2 (ja) アミノメチレンで置換した非芳香族複素環式化合物及びサブスタンスｐのアンタゴニストとしての使用
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
US6747030B1 (en) Piperazine derivatives as 5-HT1B antagonists
US5514682A (en) Fused imidazole and triazole derivatives as 5-HT1 receptor agonists
US5236937A (en) Pyridinyl compounds which are useful as angiotensin ii antagonists
EP0734383B1 (en) Cyclic amide derivatives as neurokinin a antagonists
HU193941B (en) Process for production of 6-substituted-4-dialkil-tetra-hydrobenz/c,d/ indole derivatives
JP5081363B2 (ja) アミノアルキルベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体、その製造方法およびそれを含む組成物
JPH05239053A (ja) キノリン誘導体ならびにその製造方法および治療への応用
BG61893B2 (bg) Метаноантрацени като допаминови антагонисти
SK279197B6 (sk) N-benzylindoly a farmaceutické prostriedky ich obs
WO2006082872A1 (ja) １－（ピペリジン－４－イル）－１ｈ－インドール誘導体
US6235752B1 (en) Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors
DK169104B1 (da) Analogifremgangsmåde til fremstilling af N-substituerede 2-pyridylindoler eller salte deraf
US5281593A (en) Certain indole derivatives useful as leukotriene antagonists
EP1438290B1 (en) Cyclohept b!indole derivatives as spla2 inhibitors
Apelt et al. Search for histamine H3 receptor antagonists with combined inhibitory potency at N τ-methyltransferase: ether derivatives
HUT71132A (en) Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing
JP2011001309A (ja) オキシインドール誘導体及び神経細胞死抑制剤
US5622969A (en) Method of treating leukotriene caused diseases with N-benzyl dihydroindole LTD4 antagonists